Analysis of Serum Homocysteine and Risk of Coronary Heart Disease in Patients with Pseudoexfoliation Syndrome.
10.3341/jkos.2016.57.3.461
- Author:
Byoung Young GU
1
;
Ji Hee CHU
;
Su Ho LIM
;
Soon Cheol CHA
Author Information
1. Department of Ophthalmology, Yeungnam University College of Medicine, Daegu, Korea. sccha@yumail.ac.kr
- Publication Type:Original Article
- Keywords:
Coronary heart disease;
Exfoliation syndrome;
Framingham risk score;
Homocysteine;
Pseudoexfoliation syndrome
- MeSH:
Coronary Disease*;
Exfoliation Syndrome*;
Homocysteine*;
Humans;
Hyperhomocysteinemia;
Prospective Studies
- From:Journal of the Korean Ophthalmological Society
2016;57(3):461-467
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To investigate levels of serum homocysteine in patients with pseudoexfoliation syndrome and the association between serum homocysteine levels and risk of coronary heart disease. METHODS: From March 2013 to September 2013, 37 patients with pseudoexfoliation syndrome and 59 age-matched patients (control group) were enrolled in this prospective study. Serum homocysteine levels were compared between the 2 groups. We compared the estimated 10-year risk of coronary heart disease based on Framingham risk score between the 2 groups. Additionally, we analyzed correlations between risk of coronary heart disease and serum homocysteine levels. RESULTS: The mean homocysteine level of patients with pseudoexfoliation syndrome was significantly higher than the control group (13.3 ± 6.8 µmol/L vs. 10.0 ± 5.2 µmol/L, p = 0.009). The rate of high risk defined as a 10-year coronary heart disease risk >20% in the patients with pseudoexfoliation syndrome was significantly higher than in the control group (21.4% vs. 4.4%, p = 0.048). Correlation between serum homocysteine levels and estimated 10-year risk of coronary heart disease was statistically significant (r = 0.578, p < 0.001). CONCLUSIONS: Hyperhomocysteinemia and high risk of coronary heart disease were observed in patients with pseudoexfoliation syndrome. Therefore, we suggest efforts to prevent coronary heart disease in pseudoexfoliation syndrome patients with hyperhomocysteinemia are necessary.
